Anti-Aging Effect Of Apigenin Through Modulating Mitochondrial Dysfunction, Cellular Senescence, And miR-34a In D-Galactose Induced Brain Aging In Mice | ||
| The Egyptian Journal of Hospital Medicine | ||
| Volume 101, Issue 1, October 2025, Pages 5142-5153 PDF (890.85 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejhm.2025.428202.1850 | ||
| Authors | ||
| Nada Hashem Ayad* 1; Marwa Mahmoud Awad2; Rehab Ahmed El-Shaer2; Hoda Ali Mohammed Ibrahim3; Sarah Ibrahim4; Norhan Ahmed AbuoHashish5; Sarah Ragab Abd El-Khalik6 | ||
| 1Medical Biochemistry and Molecular Biology,Faculty of Medicine,Tanta University,Tanta,Egypt | ||
| 2Physiology Department ,Faculty of Medicine ,Tanta University, Egypt | ||
| 3Medical Biochemistry &Molecular Biology Department, Faculty of Medicine, Tanta University, Egypt. | ||
| 4Human Anatomy& Embryology Department, Faculty of Medicine, Tanta University, Egypt | ||
| 5Clinical pharmacology Department. Faculty of medicine .tanta university | ||
| 6Medical Biochemistry & Molecular Biology Department ,Faculty of Medicine ,Tanta University, Egypt | ||
| Abstract | ||
| Background: Brain aging is gradual deterioration of brain functions, including cognitive impairment. Apigenin is a natural anti-oxidant. Objective: This study aims to evaluate the anti-aging impact of apigenin on D-galactose-induced brain aging via modulating mitochondrial dysfunction, cellular senescence, redox status and miR-34a. Materials and methods: Thirty mice were randomly allocated into control group (0.9% saline + dimethyl sulfoxide orally), D-galactose group, D-galactose/apigenin group. D-galactose was subcutaneously injected (150 mg/kg/day). Apigenin was given orally (20 mg/kg/day). All chemicals were administrated for eight weeks. Object location recognition (OLR) test was conducted. Senescence associated β-galactosidase (SA-β-gal) enzyme activity, gene expression, and immunohistochemical expression levels of P16, the super oxide dismutase (SOD) activity, reactive oxygen species (ROS), and malondialdehyde (MDA) levels, gene expression levels of miR-34a, and mitochondrial dynamics markers mitofusin -2 (MFN-2) and fission 1 (Fis-1) were assayed. Results: The OLR test showed impaired memory in D-galactose group, which was ameliorated by apigenin. D-galactose group showed decreased Fis-1 levels, and SOD activity, and increased activity of SA-β-gal, levels of MFN-2, ROS, MDA, and gene expression of miR-34a and p16. Apigenin administration helped in maintaining mitochondrial homeostasis, increased SOD activities, reduced MDA, ROS levels, SA-β-gal activities and expression levels of miR-34a and p16 in D-galactose/apigenin group. Conclusion: Collectively, apigenin might have anti-aging effect through modulating mitochondrial dysfunction, cellular senescence, redox status, and miR-34a expression. | ||
| Keywords | ||
| brain aging; apigenin; senescence; mitochondrial dysfunction; miR-34a | ||
|
Statistics Article View: 9 PDF Download: 3 |
||
